Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.
WuXi AppTec Co., Ltd. has announced an adjustment to the upper limit of the price for its 2025 First Share Repurchase Plan. The company has decided to increase the upper limit to RMB114.15 per share, reflecting confidence in its future development and the value of its shares. This adjustment comes in response to the rising price of the company’s A Shares, ensuring the smooth implementation of the repurchase plan. As of July 28, 2025, WuXi AppTec has repurchased 6,514,425 A Shares, utilizing approximately RMB497 million.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a company incorporated in the People’s Republic of China that operates in the biotechnology and pharmaceutical industry. It focuses on providing comprehensive and integrated services for drug development and manufacturing, catering to pharmaceutical and healthcare companies globally.
Average Trading Volume: 6,867,737
Technical Sentiment Signal: Buy
Current Market Cap: HK$281.7B
For an in-depth examination of 2359 stock, go to TipRanks’ Overview page.